Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.79 USD | -3.79% | -31.39% | -42.22% |
02:12pm | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
05-14 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.22% | 143M | |
+12.56% | 227B | |
+12.81% | 192B | |
+16.69% | 136B | |
+28.87% | 108B | |
+1.29% | 64.07B | |
+17.33% | 52.1B | |
+6.74% | 51.87B | |
+9.96% | 44.33B | |
+4.89% | 36.75B |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- JPMorgan Adjusts Price Target on Akoya Biosciences to $10 From $12, Maintains Overweight Rating